Eli Lilly Message Board - Msg: 34926056

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 884.54

+2.9%

Apr 25 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: zax	11/26/2024 3:16:37 PM
	of 634

Eli Lilly Pops After Biden Proposes Medicare Cover Obesity Drugs. Is Lilly Stock A Buy? investors.com The proposal would increase usage of drugs like Lilly's Zepbound and Novo Nordisk's ( NVO) Wegovy. Today, Medicare doesn't pay for obesity treatments unless they're used for a related condition, like diabetes or reducing the risk of heart attacks or strokes. But the proposal requires a 60-day comment period, so it will be up President-elect Donald Trump's administration whether it goes into effect. Incoming Secretary of the Department of Health and Human Services, Robert F. Kennedy Jr., has been skeptical about weight-loss drugs. But Dr. Mehmet Oz, who Trump has tapped to lead Medicare, has praised them, according to NBC News. BMO Capital Markets analyst Evan Seigerman recently said a Kennedy-tied selloff is overdone. Kennedy "remains limited in his ability to influence either policy or pricing of obesity medications," Seigerman said in a report. </snip> Read the rest here: investors.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next